Researchers developed a revolutionary hydrogel containing dimeric copper peptides that achieved 97.2% closure of diabetic wounds. The treatment combines enhanced stability against enzyme breakdown with intelligent drug release triggered by wound inflammation. This dual-action approach addresses multiple healing barriers simultaneously, offering hope for the millions suffering from chronic diabetic wounds that often lead to amputation.
